A genome-wide association study identifies susceptibility loci for ovarian cancer at 2q31 and 8q24
Ellen L. Goode(Mayo Clinic), The Australian Cancer Study (Ovarian Cancer)(QIMR Berghofer Medical Research Institute), The Australian Ovarian Cancer Study Group(University of Cambridge), Georgia Chenevix‐Trench(University College London), Honglin Song(University College London), Susan J. Ramus(University College London), Maria Notaridou(University College London), Kate Lawrenson(Mayo Clinic), Martin Widschwendter(Mayo Clinic), Robert A. Vierkant(Rigshospitalet), Melissa C. Larson(Massachusetts General Hospital), Susanne K. Kjær(Duke Medical Center), Michael J. Birrer(Duke Medical Center), Andrew Berchuck, Joellen M. Schildkraut(Radboud University Nijmegen), Ian Tomlinson(University of New Mexico), Lambertus A. Kiemeney(International Hereditary Cancer Center), Linda S. Cook(National Institutes of Health), Jacek Gronwald(Royal Marsden Hospital), Montserrat García‐Closas(Peter MacCallum Cancer Centre), Martin Gore(Stanford University), Ian Campbell(University of South Florida), Alice S. Whittemore(Moffitt Cancer Center), Rebecca Sutphen(University of California, Irvine), Catherine Phelan(University of Southern California), Hoda Anton‐Culver(Vlaams Instituut voor Biotechnologie), Celeste Leigh Pearce(Fred Hutch Cancer Center), Diether Lambrechts(German Cancer Research Center), Mary Anne Rossing(Roswell Park Comprehensive Cancer Center), Jenny Chang‐Claude(University of Hawaiʻi at Mānoa), Kirsten B. Moysich(Medizinische Hochschule Hannover), Marc T. Goodman(Helsinki University Hospital), Thilo Dörk(The University of Texas Health Science Center at Houston), Heli Nevanlinna(deCODE Genetics (Iceland)), Roberta B. Ness(Rigshospitalet), Þórunn Rafnar(Danish Cancer Society), Claus Høgdall(Mayo Clinic), Estrid Høgdall(Mayo Clinic), Brooke L. Fridley(University of South Florida), Julie M. Cunningham(University of South Florida), Weiva Sieh(Fox Chase Cancer Center), Valerie McGuire(Brigham and Women's Hospital), Andrew K. Godwin(National Institutes of Health), Daniel W. Cramer(Memorial Sloan Kettering Cancer Center), Dena Hernández(The University of Texas MD Anderson Cancer Center), Douglas A. Levine(Duke University), Karen H. Lu(University of North Carolina at Chapel Hill), Edwin S. Iversen(Institute of Cancer Research), Rachel T. Palmieri(Radboud University Nijmegen), Richard S. Houlston(Netherlands Comprehensive Cancer Organisation), Anne M. van Altena(Radboud University Nijmegen), Katja K.H. Aben(BC Cancer Agency), Leon F.A.G. Massuger(Alberta Health Services), Angela Brooks‐Wilson(BC Cancer Agency), Linda E. Kelemen(International Hereditary Cancer Center), Nhu D. Le(University of New Mexico), Anna Jakubowska(International Hereditary Cancer Center), Jan Lubiński(University of Cambridge), Krzysztof Mędrek(University of Cambridge), A. Stafford(University of Cambridge), Douglas F. Easton(University of Cambridge), Jonathan P. Tyrer(University of Cambridge), Kelly L. Bolton(Princess Anne Hospital), Patricia Harrington(Moffitt Cancer Center), Diana Eccles(Stanford University), Ann Chen(Stanford University), Ashley N Molina, Barbara N Davila(Moffitt Cancer Center), Hector Arango(Moffitt Cancer Center), Ya-Yu Tsai(Yale University), Zhihua Chen(Cancer Care Ontario), Harvey A. Risch(University of Toronto), John McLaughlin(University of California, Irvine), Steven A. Narod(University of North Carolina at Chapel Hill), Argyrios Ziogas(University College London), Wendy R. Brewster(University College London), Aleksandra Gentry‐Maharaj(University of Southern California), Usha Menon(University of Southern California), Anna H. Wu(University of Southern California), Daniel O. Stram(QIMR Berghofer Medical Research Institute), Malcolm C. Pike(QIMR Berghofer Medical Research Institute), Jonathan Beesley, Penelope M. Webb
Cited by 352Open Access
Abstract
Related Papers
No related papers found
Powered by citation graph analysis